Pediatric Psychopharmacology for Primary Care, 3rd Edition [Paperback]

Name: Pediatric Psychopharmacology for Primary Care, 3rd Edition [Paperback]
Brand: American Academy of Pediatrics
SKU: 9BE2AE9F-4E6C-4722-91AF-39322954F333

Editor: Mark A. Riddle, MD

Buy Print Book and Save 50% on eBook with this exclusive package offer! Click here to order.

Format

Price: $91.95

Member Price: $73.95

Quantity

The amount must be greater than 0

Product Information

Description

The revised and updated third edition of this best-selling resource provides primary care physicians with practice-tested, condition-specific treatment recommendations for various mental and psychiatric disorders or behavioral problems in children and adolescents.

Obtain clear guidance on dosing, monitoring, and potential adverse reactions of psychotropic medications. Ease medication decision-making with a clear, straightforward methodology based on current research and clinical experience. This simple, systematic approach defines discrete levels of psychotropics and describes their group-specific roles and responsibilities in accordance with American Academy of Pediatrics policies. The accompanying digital tool offers instant access to authoritative answers on specific conditions and psychotropic medications.

Topics include

Conceptual framework for prescribing psychotropics
Newly approved medications, changes in regulations and guidelines, and updates in the professional literature
Disrupted sleep and the use of sleep aids
Medications for specific diagnoses—ADHD, anxiety, and depression
US Food and Drug Administration–approved antipsychotics and mood stabilizers and all other medications
How to manage treatment impasses

Details

ISBN-13: 978-1-61002-546-1
Product Code: MA1027
Publication Date: October 15, 2021
Format: Paperback
Pages: 232
Publisher: American Academy of Pediatrics
Availability: In Stock

About the Authors

Editor

Mark A. Riddle, MD

Mark A. Riddle, M.D., Professor of Psychiatry and Pediatrics and Director of the Children’s Interventions Research Program in Psychiatry at the Johns Hopkins University School of Medicine is the editor in chief. The focus of Dr. Riddle’s research, teaching and clinical practice is pediatric psychopharmacology, especially medication side effects. His publications include over 240 research articles, reviews, chapters and edited volumes. He serves as a member of the NICHD-sponsored Data Monitoring Board for the Best Pharmaceuticals for Children Act and as a member of the Institute of Medicine’s Committee on Review of Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act. He is the principle investigator of an NIMH-sponsored, multisite study of interventions for children who have gained weight on antipsychotic medication, and the site-PI of a 6-year follow-up study of preschoolers who were treated with medication for ADHD. He was the Director of the Division of Child and Adolescent Psychiatry at Johns Hopkins from 1993-2009 and was the founding chair of the Interventions Review Committee for Disorders Involving Children and Their Families at the National Institute of Mental Health.